A nurse is caring for a 38-year-old client with autosomal do… | 마이메르시 MyMerci
마이메르시 — 문제와 상세 해설까지 전부 무료 무료로 시작하기
Adult Health
문제

A nurse is caring for a 38-year-old client with autosomal dominant polycystic kidney disease (PKD) admitted for routine monitoring. The client reports occasional flank pain and has a family history of kidney disease. Which nursing intervention should be prioritized to prevent the most serious complication?

A 45-year-old client with autosomal dominant polycystic kidney disease is admitted for routine monitoring. The client reports occasional flank pain and has a family history of kidney disease.
해설
Hypertension is the most common and serious complication of PKD, requiring priority monitoring and management to slow disease progression. Other interventions like fluid intake, pain management, or protein restriction are supportive but not primary for preventing this complication.
같은 주제 다음 문제A nurse is assessing a 45-year-old client with a family history of polycystic kidney disea…

심화 해설

Understanding the Priority: Preventing the Most Serious Complication

In autosomal dominant polycystic kidney disease (ADPKD), the pathophysiology extends beyond the kidneys. The genetic mutation leads to the formation of fluid-filled cysts that disrupt normal renal architecture, but it also causes systemic vascular dysfunction. The most serious and life-threatening complication in ADPKD is not kidney failure alone, but the cardiovascular and cerebrovascular events driven by uncontrolled hypertension. Intracranial aneurysm rupture and progressive heart failure are leading causes of premature death in this population. Therefore, the highest priority nursing intervention is rigorous blood pressure monitoring and management.

Why Blood Pressure Control is the Priority

The renin-angiotensin-aldosterone system (RAAS) is activated early in ADPKD because expanding cysts compress the renal vasculature, causing intrarenal ischemia. This drives systemic hypertension long before a measurable decline in glomerular filtration rate (GFR) occurs. Hypertension then accelerates cyst growth and renal function decline, creating a vicious cycle. The 2025 KDIGO guideline update emphasizes that strict blood pressure control is the cornerstone of care to slow disease progression and prevent cardiovascular complications [1]. While all listed interventions are important components of holistic care, they do not address the immediate, life-threatening risk of vascular events with the same urgency.

Analysis of Nursing Interventions























InterventionRationale & Priority Analysis
1. Encourage increased fluid intake to 3-4 liters per day Increased water intake suppresses vasopressin, a hormone that promotes cyst growth. This is a key disease-modifying strategy recommended in the guidelines [1]. However, its effect is long-term and supportive; it does not directly prevent an imminent hypertensive crisis or stroke.
2. Administer prescribed analgesics for pain management Flank pain is a common symptom from cyst expansion, hemorrhage, or infection. Pain management is essential for comfort but addresses a symptom, not the most serious systemic complication. An acute change in pain character could signal cyst rupture or infection, requiring further assessment, but routine analgesia is not the top safety priority.
3. Monitor blood pressure closely and implement hypertension management This is the correct priority. Given the direct link between hypertension and both accelerated renal decline and catastrophic events like intracranial aneurysm rupture, meticulous BP monitoring and adherence to a strict target (often lower than the general population) is the most critical nursing action to prevent the most serious complication [1].
4. Provide dietary education about protein restriction Dietary modification is important as kidney function declines. However, in early ADPKD with preserved renal function, aggressive protein restriction is not the primary intervention and does not take precedence over cardiovascular risk reduction. The focus is on sodium restriction to support blood pressure control.


Clinical Application of the Guideline Update

The Canadian Society of Nephrology commentary on the 2025 KDIGO guidelines reinforces that management must be tailored, but the fundamental principle remains: early and aggressive cardiovascular risk factor modification, with blood pressure control at the forefront, is non-negotiable [1]. For a nurse admitting a client for routine monitoring, the immediate clinical judgment involves assessing for a blood pressure that may be dangerously elevated, even if the client reports only "occasional flank pain." A blood pressure reading consistently above target is a finding that requires prompt intervention and provider notification to prevent a stroke or myocardial infarction, making this the unequivocal nursing priority.
References (research sources)
  • [1]
    Canadian Society of Nephrology Commentary on the 2025 Kidney Disease Improving Global Outcomes Clinical Practice Guidelines for Autosomal Dominant Polycystic Kidney Disease.GuidelineLanktree MB, Ashawasega N, Bevilacqua M, Bichet DG, Bollée G, Brown PA, Girard L, Goodyer P, Hingwala J, Lemaire M, McFarlane P, Moist L, Pei Y, Proulx N, Schott C, Soroka S, Vlasschaert C, Watkins N, Alam A. (2026) · DOI: 10.1177/20543581261455635

임상 시나리오

Clinical Practice Guide: ADPKD & Hypertension Management

In autosomal dominant polycystic kidney disease (ADPKD), the priority is preventing catastrophic vascular events. The 2025 KDIGO guideline update emphasizes that strict blood pressure control is the cornerstone of care to slow disease progression and prevent cardiovascular complications.

  • Target BP: Maintain blood pressure at or below 110/75 mmHg in young, healthy adults (18-50 years) with ADPKD and preserved renal function, as this target has shown efficacy in slowing total kidney volume growth.
  • First-Line Agents: RAAS blockers, such as ACE inhibitors or ARBs, are the preferred antihypertensives due to their dual role in controlling systemic pressure and reducing intraglomerular pressure.
  • Monitoring Frequency: Blood pressure should be assessed at every clinical encounter. Home BP monitoring is encouraged for tight control and early detection of worsening hypertension.
  • Screening for Aneurysms: Magnetic resonance angiography (MRA) screening for intracranial aneurysms is recommended for ADPKD patients with a family history of hemorrhagic stroke or aneurysm, as uncontrolled hypertension is a major risk factor for rupture.
  • Lifestyle Integration: Sodium restriction (

핵심 개념

  • Autosomal Dominant Polycystic Kidney Disease (ADPKD) — A genetic disorder characterized by the growth of numerous cysts in the kidneys, leading to hypertension, kidney enlargement, and eventual renal failure, often associated with extrarenal manifestations like intracranial aneurysms.
  • Renin-Angiotensin-Aldosterone System (RAAS) — A hormone system that regulates blood pressure and fluid balance; in ADPKD, it is activated early due to cyst-induced intrarenal ischemia, driving systemic hypertension.
  • KDIGO Guidelines — Kidney Disease: Improving Global Outcomes guidelines, which provide evidence-based recommendations for the management of chronic kidney disease, including strict blood pressure targets in ADPKD.
  • Intracranial Aneurysm — A weakened, bulging area in the wall of an artery in the brain; a serious extrarenal complication of ADPKD that can rupture, causing hemorrhagic stroke, and is linked to uncontrolled hypertension.
Merci NCLEX-RN Question Bank 3,445 문제 · 로그인 없이 바로 볼 수 있어요

마이메르시로 국가고시 완벽 대비

기출문제와 상세 해설을 무료로. 내 약점을 분석하고 진도를 관리하며 더 똑똑하게 공부하세요.

무료로 시작하기

학습 참고용입니다. 실제 임상은 최신 지침과 소속 기관 프로토콜을 따르세요.